Skip to main content
Premium Trial:

Request an Annual Quote

Varian: Phil Febbo

Varian has appointed Phil Febbo to its board of directors. Febbo currently serves as chief medical officer at Illumina as well as on the board of the American College of Medical Genetics and Genomics Foundation. Prior to joining Illumina, he served as CMO at Genomic Health. Before working at Genomic Health, Febbo was a professor of medicine and urology at the University of California, San Francisco. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.